418 related articles for article (PubMed ID: 22321707)
1. [Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
Zeng XL; Liu XJ; Bao HR; Zhang Y; Tan EL; Liao JM
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):743-8. PubMed ID: 22321707
[TBL] [Abstract][Full Text] [Related]
2. [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis].
Zhao CY; Wang YD; Zhou JY; Jia B; Cui JF
Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):450-5. PubMed ID: 17594812
[TBL] [Abstract][Full Text] [Related]
3. [The protective effects and mechanisms of peroxisome proliferator-activated receptor-gamma agonist in rats with acute lung injury].
Wang JC; Jiang P; Huang J; Qian GS
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):425-30. PubMed ID: 19031802
[TBL] [Abstract][Full Text] [Related]
4. [The role of peroxisome proliferator-activated receptor-γ/nuclear factor-ΚB transduction pathway on coagulation disorders induced by sepsis].
Sun Y; Wang J; Yu L; Dai L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):520-4. PubMed ID: 26049195
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
[TBL] [Abstract][Full Text] [Related]
6. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
7. [Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome].
Luo YM; Wan XH; Jiang DQ; Kuang WY; Guo HB; Chen ZX; Wang HJ; Xie LH; Duan W
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):739-45. PubMed ID: 20021931
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
[TBL] [Abstract][Full Text] [Related]
9. Trans-10, cis-12 conjugated linoleic acid and the PPAR-γ agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-α production by bovine immune cells.
Perdomo MC; Santos JE; Badinga L
Domest Anim Endocrinol; 2011 Oct; 41(3):118-25. PubMed ID: 21798687
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).
Lakshmi SP; Reddy AT; Zhang Y; Sciurba FC; Mallampalli RK; Duncan SR; Reddy RC
J Biol Chem; 2014 Mar; 289(10):6383-6393. PubMed ID: 24368768
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N
Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
[TBL] [Abstract][Full Text] [Related]
16. [Effect of nuclear factor-kappaB on peroxisome proliferator activated receptor gamma expression in Ana-1 cells].
Xiao B; Wang JC; Wang GS; Ji FY; Xu J
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):3-7. PubMed ID: 19141181
[TBL] [Abstract][Full Text] [Related]
17. [The proteasome inhibitor MG132 attenuates skeletal muscle atrophy in a rat model of chronic obstructive pulmonary disease].
Ma BM; Liu ZH; Liang ZK; Guan LJ; Wang XL
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):441-6. PubMed ID: 24103208
[TBL] [Abstract][Full Text] [Related]
18. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
[TBL] [Abstract][Full Text] [Related]
19. [Effects of sulforaphane on Toll-like receptor 4/myeloid differentiation factor 88 pathway of monocyte-derived macrophages from patients with chronic obstructive pulmonary disease].
Zeng X; Liu X; Bao H; Zhang Y; Wang X; Shi K; Pang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Apr; 37(4):250-4. PubMed ID: 24969711
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
